• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more

News
Article

The latest news for pharma industry insiders.

Nov. 27 is Here: What Does That Mean for DSCSA?

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Researchers to Clinicians: Don’t Neglect the Neuropsychiatric Symptoms of Friedreich’s Ataxia

Poor balance and coordination are prominent features of Friedreich’s ataxia (FRDA). Czech researchers found that neuropsychiatric symptoms are also common among patients with FRDA.

Thank Big Data for Killing Off the Worst Part of Thanksgiving Meal Prep

Butterball started out with a boring, standard software implementation—and ended with the creation of a Thanksgiving turkey that you do not need to thaw.

AbbVie Digital Transformation Strategy Report 2024

The "Enterprise Tech Ecosystem Series: AbbVie Inc. - 2024" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into AbbVie's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Pharmaceutical Executive on LinkedIn

Happy Thanksgiving to all of our readers, listeners, experts, and clients! We're so thankful for all of the voices that help Pharmaceutical Executive be an authority in the pharma industry.
Looking forward to finishing out 2024 strong, and preparing to hit the ground running in 2025!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs